Skip to content
Delayed ~15 min

VERA VERA THERAPEUTICS CLASS A

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 20 analyst firms say about VERA THERAPEUTICS CLASS A: their latest ratings, price targets and how far the stock is from them. How it works

29.79 USD−0.36 (−1.18%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+160.9%to the avg target 77.71 USD+47.92 USD
Buy 14 · Hold 3 · Sell 0

17 rated views · 20 analyst/firm records · 20 firms

Latest report23 Oct 2026avg report date 9 Aug
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8076
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8056

Recent analyst activity · last 90 days

Our tracked history has 16 reports on VERA from 13 analyst firms in the last 90 days (20 firms in the past year).

Comparing each firm's latest target with its previous one: 4 lowered it, 5 left it unchanged and 3 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Jefferies lowered its target from $60.00 (set 2 Jun 2026) to $59.00 on 16 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Bank of America SecuritiesDina RamadaneBuy7 Jul 202670.00 USD
Cantor FitzgeraldPete StavropoulosBuy23 Oct 2026100.00 USD
Evercore ISIGavin Clark-GartnerBuy14 Aug 202691.00 USD
Goldman SachsPaul K ChoiBuy14 May 202680.00 USD
GuggenheimVamil DivanBuy17 Aug 202676.00 USD
H.C. WainwrightArthur HeBuy12 Aug 202690.00 USD
JefferiesFarzin HaqueBuy16 Sep 202659.00 USD
JPMorganAnupam RamaBuy8 Sep 202683.00 USD
Leerink PartnersWill SoghikianHold12 Oct 202634.00 USD
Lifesci CapitalRami KatkhudaBuy2 Jun 202690.00 USD
NeedhamUnnamed analyst—8 Jul 2026125.00 USD
Pivotal ResearchUnnamed analyst—5 Dec 202573.00 USD
Raymond JamesRyan DeschnerBuy26 Oct 202684.00 USD · 15 Sep 2026
TD CowenRitu BaralBuy15 Sep 202678.00 USD
WedbushLaura ChicoHold19 Oct 202634.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
Wells FargoMohit BansalBuy15 Oct 202670.00 USD
William BlairUnnamed analystBuy2 Jun 2026—
Wolfe ResearchAndy G ChenBuy11 Sep 202684.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026Conflicting reports · excluded

Partial coverage · checked 6 Nov (6 Nov 2026, 02:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.